ETOPOSIDE (VP16) IN THE TREATMENT OF MULTISYSTEM LANGERHANS CELL HISTIOCYTOSIS (HISTIOCYTOSIS-X)

被引：62

作者：

BROADBENT, V ^{[1
]}

PRITCHARD, J ^{[1
]}

YEOMANS, E ^{[1
]}

机构：

[1] HOSP SICK CHILDREN,DEPT HAEMATOL & ONCOL,LONDON WC1N 3JH,ENGLAND

来源：

MEDICAL AND PEDIATRIC ONCOLOGY | 1989年 / 17卷 / 02期

关键词：

D O I：

10.1002/mpo.2950170205

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：97 / 100

页数：4

共 17 条

[1]

AMBRUSO DR, 1980, CANCER, V45, P2516, DOI 10.1002/1097-0142(19800515)45:10<2516::AID-CNCR2820451008>3.0.CO

[2]

2-V

[3] HISTIOCYTOSIS-X - CURRENT CONTROVERSIES [J].

BROADBENT, V ;

PRITCHARD, J .

[4]

BROADBENT V, 1984, LANCET, V1, P253

[5]

CECI A, 1987, IN PRESS MED PED ONC

[6]

CHU A, 1987, LANCET, V8526, P208

[7]

DUNGAR D, 1988, IN PRESS ACTA ENCOCR

[8]

HOCKING WG, 1986, CANCER, V58, P840, DOI 10.1002/1097-0142(19860815)58:4<840::AID-CNCR2820580405>3.0.CO

[9]

2-Y

[10] HISTIOCYTOSIS-X - ANALYSIS OF PROGNOSTIC FACTORS [J].

LAHEY, ME .